NEW YORK, May 1, 2024 /PRNewswire/ – Ascend Wellness Holdings, Inc. (“AWH,” “Ascend” or the “Company”) (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, proudly announces support for the reports citing the Drug Enforcement Agency’s (“DEA”) decision to accept the recommendation of the U.S. Department of Health and Human Services (“HHS”) to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (“CSA”).
× This page requires Javascript.
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Trending Stories
